Overview

A hypercoagulable disorder, also known as thrombophilia, is an inherited or acquired condition that makes the blood more likely to form blood clots. Normally, clotting is part of the body’s healing process, helping stop bleeding after injury. In hypercoagulable disorders, something goes wrong in this clotting process, leading to inappropriate or excessive clot formation, even without injury.

These clots can travel through the bloodstream and block vessels in places like the lungs (pulmonary embolism), legs (deep vein thrombosis), or brain (stroke). Some individuals may never experience a clot, while others may face life‑threatening events.

Causes

Hypercoagulable disorders may be:

Inherited (Genetic Thrombophilia)

Some people are born with gene mutations that increase clotting risk. Examples include:

  • Factor V Leiden mutation
  • Prothrombin gene mutation (G20210A)
  • Protein C, Protein S, or Antithrombin deficiencies

Acquired Thrombophilia

These develop later in life due to:

  • Autoimmune conditions like antiphospholipid syndrome
  • Liver disease or some cancers
  • Surgery, immobility, pregnancy, or certain medications

Nearly 90% of people with hereditary thrombophilia never develop a blood clot, but certain forms carry significantly higher risk.

Symptoms

Hypercoagulable disorders don’t always cause symptoms unless a clot forms. Symptoms depend on where the clot occurs.

Signs of Blood Clots May Include:

Swelling

pain, or warmth in an arm or leg (possible DVT)

Chest pain

sudden shortness of breath (possible pulmonary embolism)

Vision changes

confusion, or sudden weakness (stroke‑like symptoms)

Unexplained abdominal pain

Clots in veins often cause swelling or pain, while arterial clots may cause more severe complications like a heart attack or stroke.

How We Diagnose It

Evaluation may include:

Blood tests to look for clotting factor abnormalities

Genetic testing for inherited thrombophilia

Imaging studies if a clot is suspected

Not all patients need thrombophilia testing. Guidelines suggest testing when results could influence future treatment or anticoagulation decisions.

Treatment Options

Treatment depends on the type of thrombophilia, whether clots have occurred, and individual risk factors.

Medications such as warfarin or DOACs keep blood from clotting too easily and are used to treat or prevent clots.

  • Avoid long periods of immobility
  • Maintain a healthy weight
  • Stay well hydrated during travel or inactivity
  • Discuss risks before pregnancy or surgery
  • Avoid estrogen‑containing medications when appropriate

Some cancers and cancer treatments increase clot risk. These situations may require ongoing monitoring and preventive medication.

Living With a Hypercoagulable Disorder

Many people with thrombophilia live long, healthy lives, particularly when they understand their risks and take steps to prevent clots. Some individuals may require long‑term blood thinners, while others only need treatment during high‑risk periods (such as after surgery or during pregnancy).

Regular follow‑up with your care team ensures safe monitoring of clot risk and medication levels.

When To See Your Provider

Seek medical attention right away if you experience:

Leg pain

Sudden swelling or pain in an arm or leg

Chest pain

Shortness of breath or sharp chest pain

Headache

Severe headache, confusion, or stroke‑like symptoms

These may signal a serious or life‑threatening clot.

Why Choose Illinois CancerCare

A blood disorder diagnosis can feel overwhelming. At Illinois CancerCare, we are committed to ensuring you never have to face it alone. Providing advanced, comprehensive hematology and oncology care for our patients is at the heart of everything we do. Since 1977, our specialists have focused on individualized, evidence-based treatment plans, access to world-class clinical trials, and thorough follow-up. With Illinois CancerCare, you can move forward with confidence knowing trusted expertise and compassionate support are always close to home.‑based treatment plans, access to world‑class clinical trials, and thorough follow‑up.

Sources & Patient Friendly References

Information sourced from Cleveland Clinic and Stop the Clot.